Dyslipidemia intervention in metabolic syndrome: emphasis on improving lipids and clinical event reduction

Am J Med Sci. 2011 May;341(5):388-93. doi: 10.1097/MAJ.0b013e31821483fa.


The metabolic syndrome is a common disorder characterized by central (especially intra-abdominal) obesity, hypertension, impaired glucose tolerance and atherogenic dyslipidemia (including the combination of hypertriglyceridemia and low levels of high-density lipoprotein cholesterol). In this article, the authors review interventions to improve this lipid profile and potentially reduce the risk of major cardiovascular events in patients with metabolic syndrome.

Publication types

  • Review

MeSH terms

  • Cardiovascular Diseases / prevention & control*
  • Dyslipidemias / blood
  • Dyslipidemias / drug therapy*
  • Humans
  • Hypolipidemic Agents / therapeutic use
  • Lipids / blood*
  • Metabolic Syndrome / complications*
  • Risk Factors


  • Hypolipidemic Agents
  • Lipids